Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer
Condition(s):Prostate CancerLast Updated:June 16, 2011Completed
Hide Studies Not Open or Pending
Condition(s):Prostate CancerLast Updated:June 16, 2011Completed
Condition(s):MenopauseLast Updated:February 4, 2009Completed
Condition(s):PostmenopauseLast Updated:September 23, 2010Completed
Condition(s):Estrogen; Menopause; Pelvic Floor Disorders; SurgeryLast Updated:May 2, 2018Withdrawn
Condition(s):PostmenopauseLast Updated:December 6, 2007Completed
Condition(s):Atrophic VaginitisLast Updated:May 28, 2007Completed
Condition(s):Overactive BladderLast Updated:April 20, 2017Unknown status
Condition(s):Healthy; Estrogen Replacement TherapyLast Updated:July 9, 2009Completed
Condition(s):Increased Risk for Development of Breast CancerLast Updated:January 26, 2024Active, not recruiting
Condition(s):PostmenopauseLast Updated:June 22, 2010Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.